RESEARCH-USE BIOSIMILAR ANTIBODY
Rovelizumab
Monoclonal antibody · IgG4
Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke.
TARGETITGAL
YMonoclonal antibody
TARGETITGB2
CATALOG NUMBERSC-BS-202
MOLECULAR WEIGHTApprox. 145.98 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke.
Rovelizumab is a recombinant research-use antibody directed against ITGAL / ITGB2 / CD11a.